The Evidence Behind 'Screen and Refer': What Supports the Push to Treat Isolation with Technology

The recommendation now circulating through primary care, geriatrics, and cardiology is specific enough to evaluate: clinicians should routinely screen patients, particularly older ones, for social isolation and loneliness, and where isolation is identified, refer patients toward increased social contact – often specified as including video calls, connection apps, or other technology-mediated substitutes for in-person contact. The 2020 National Academies consensus report on isolation in older adults made the screening half of this recommendation explicit, calling on the health care system to build assessment into routine care. The American Heart Association’s 2022 scientific statement went further, treating isolation as a cardiovascular risk factor deserving the same clinical attention as blood pressure or cholesterol.

What is worth separating out is which half of this two-part recommendation the evidence actually supports.

The association is not in dispute

The mortality data behind the recommendation are unusually consistent for social science. Julianne Holt-Lunstad’s 2010 meta-analysis, pooling 148 studies and 308,849 participants, found that stronger social relationships were associated with a 50% increased likelihood of survival – an effect size the authors explicitly compared to established risk factors like smoking cessation. Her 2015 follow-up, focused specifically on isolation and loneliness rather than relationship quality generally, found more modest but still substantial odds ratios: 1.29 for social isolation, 1.26 for loneliness, 1.32 for living alone, with effects holding after adjustment for baseline health status. The AHA’s 2022 statement, led by Crystal W. Cene on behalf of several of the organization’s councils, translated this into cardiovascular terms specifically: roughly 29% increased risk of heart attack or death from heart disease, and 32% increased risk of stroke, associated with isolation and loneliness.

This is a genuinely strong evidence base for the claim that isolation and loneliness predict poor health outcomes. It is not, however, evidence that screening for isolation and then intervening – with technology or anything else – changes those outcomes. That is a different empirical question, and the same AHA statement says so directly: it names the absence of intervention evidence as the central gap in the field, not a footnote to it.

Screening evidence versus treatment evidence

The National Academies report calls for assessment; the commentary on that report published later in 2020 pushes further, arguing clinicians need routine tools for identifying isolation the way they screen for depression or fall risk. Neither document claims that assessment alone improves outcomes – the argument is that assessment is a precondition for intervention, which is reasonable as a logical matter. But it means the strength of the recommendation to screen rests on an assumption: that once isolation is identified, something effective can be done about it. That assumption is where the evidence thins considerably.

The closest thing to intervention evidence in this literature comes from social prescribing, the practice of referring patients to non-clinical community activities, including some technology-facilitated group formats. A 2021 systematic review in the International Journal of Environmental Research and Public Health found social prescribing programs associated with increases in self-esteem and self-confidence, but the review’s authors flagged limited trial evidence and substantial heterogeneity across the programs studied – different populations, different referral pathways, different definitions of what counted as a successful outcome. A second 2021 review, in Perspectives in Public Health, looked specifically at loneliness outcomes: all nine included studies reported positive effects, and three found reductions in downstream health service use. Nine studies is a small evidence base for a recommendation now being applied at population scale, and the review does not distinguish which of those nine involved technology-mediated contact as opposed to in-person referral.

A 2022 qualitative meta-synthesis in BMC Health Services Research adds a finding that complicates the technology-as-substitute framing further: participants describing benefit from social prescribing attributed it to restored meaningful participation and purpose, not contact in the abstract. Structured, purposeful activity appeared to matter more than the fact of social contact occurring. If that finding generalizes, it suggests a video call or an app-based connection, absent some structured purpose, may not reproduce the mechanism that the underlying prescribing programs actually rely on – which would be an important caveat for any recommendation that treats “increase technology-mediated contact” as functionally interchangeable with “increase social contact.”

What the Surgeon General’s advisory does and does not add

The U.S. Surgeon General’s May 2023 advisory is the most prominent recent document to bundle isolation, loneliness, and technology together, noting that around half of U.S. adults report experiencing loneliness and that the health effects are comparable in magnitude to smoking up to 15 cigarettes daily. The advisory lays out a six-pillar national strategy, one of which addresses technology’s dual role – capable of facilitating connection or substituting for it in ways that increase isolation. This is a more cautious framing than “refer to technology” as a treatment. It treats technology as a variable that can cut either direction, not a validated intervention. That caution is appropriate given what the underlying studies show, or rather do not show: none of the sources reviewed here report a randomized trial testing whether a technology-mediated connection intervention reduces isolation, loneliness, or downstream health outcomes such as cardiovascular events.

A June 2023 review in BMC Public Health, surveying the state of the field generally, reaches a similar conclusion from a methods standpoint: inconsistent measurement across studies is a persistent barrier to comparing findings, let alone establishing which interventions work. That inconsistency compounds the intervention gap. Even where a technology-based program shows a positive result in one study, differing instruments and definitions of isolation and loneliness across studies make it difficult to know whether a result would replicate under a different measurement approach.

Where the recommendation stands

The clinical case for screening is on reasonably firm empirical ground: isolation and loneliness predict mortality and cardiovascular outcomes with effect sizes comparable to established risk factors, replicated across meta-analyses spanning over 300,000 participants. The clinical case for treating identified isolation with technology-mediated contact specifically is not on firm ground, because the relevant trials do not yet exist in this literature. What exists instead is a small, heterogeneous body of social prescribing research that shows promise for structured, purposeful referral programs – not a tested case for video calls or connection apps as a stand-alone clinical treatment.

A study that would close this gap would randomize isolated patients identified through routine clinical screening to a technology-mediated connection intervention, a structured in-person social prescribing referral, and usual care, then follow all three groups for a clinical endpoint such as cardiovascular events or all-cause mortality, using a consistent, validated instrument across arms. Nothing in the current record does that. Until it does, “screen for isolation” and “prescribe technology” remain two recommendations of very different evidentiary weight, frequently issued in the same sentence.